These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32117155)

  • 1. Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics.
    Vogel OA; Manicassamy B
    Front Microbiol; 2020; 11():135. PubMed ID: 32117155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Universal Influenza Vaccines Targeting Conserved Viral Proteins.
    Jazayeri SD; Poh CL
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31683888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
    Krammer F
    Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture.
    Rajão DS; Pérez DR
    Front Microbiol; 2018; 9():123. PubMed ID: 29467737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a universal influenza vaccine: different approaches for one goal.
    Sautto GA; Kirchenbaum GA; Ross TM
    Virol J; 2018 Jan; 15(1):17. PubMed ID: 29370862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
    Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.
    Carter DM; Darby CA; Lefoley BC; Crevar CJ; Alefantis T; Oomen R; Anderson SF; Strugnell T; Cortés-Garcia G; Vogel TU; Parrington M; Kleanthous H; Ross TM
    J Virol; 2016 May; 90(9):4720-4734. PubMed ID: 26912624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine.
    Krammer F; García-Sastre A; Palese P
    Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
    He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
    J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.
    Schwartzman LM; Cathcart AL; Pujanauski LM; Qi L; Kash JC; Taubenberger JK
    mBio; 2015 Jul; 6(4):e01044. PubMed ID: 26199334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses.
    Jang YH; Seong BL
    Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33916924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.
    Fox A; Quinn KM; Subbarao K
    Drugs; 2018 Sep; 78(13):1297-1308. PubMed ID: 30088204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efforts to Improve the Seasonal Influenza Vaccine.
    Harding AT; Heaton NS
    Vaccines (Basel); 2018 Mar; 6(2):. PubMed ID: 29601497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pan-Influenza A Protection by Prime-Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model.
    Jang YH; Kim JY; Byun YH; Son A; Lee JY; Lee YJ; Chang J; Seong BL
    Front Immunol; 2018; 9():116. PubMed ID: 29449842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
    Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
    J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.